REFERENCES
- Berman S. Otitis media in children. N Engl J Med 1995; 332: 1560–1565.
- Subcommittee on Management of Acute Otitis Media, American Academy of Pediatrics and American Academy of Family Physicians. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451–65.
- Pichichero ME. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr 2006; 45: 493–502.
- Ball P, Baquero F, Cars O, File T, Garau J, Klugman K et al. The Consensus Group on resistance and prescribing in respi-ratory tract infection. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49: 31–40.
- Marchant CD, Carlin SA, Johnson CE, Shurin PA. Meas-uring the comparative efficacy of antibacterial agents for acute otitis media: the “Pollyanna phenomenon”. J Pediatr 1992; 120: 72–77.
- Dagan R, Klugman KP, Craig WA, Baquero F. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J An-timicrob Chemother 2001; 47: 129–140.
- Calbo E, Garau J. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-ac-quired respiratory tract infections. Respiration 2005; 72: 561–571.
- Craig WA. Pharmacokinetic/pharmacodynamic parame-ters: rationale for antibacterial dosing of mice and men. Clin In-fect Dis 1998; 26, 1–10; quiz 11-12.
- Poole MD. A mathematical therapeutic outcomes model for sinusitis. Otolaryngol Head Neck Surg 2004; 130: 46–50.
- Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130: 1–45.
- Canut A, Martin-Herrero JE, Labora A, Maortua H. What are the most appropriate antibiotics for the treatment of acute ex-acerbation of chronic obstructive pulmonary disease? A thera-peutic outcomes model. J Antimicrob Chemother 2007; 60: 605–612.
- Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 2003; 16: 230–241.
- Hoberman A, Marchant CD, Kaplan SL, Feldman S. Treatment of acute otitis media consensus recommendations. Clin Pediatr 2002; 41: 373–390.
- Block SL, Hedrick J, Harrison CK, Tyler R, Smith A, Find-lay R et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23: 829–833.
- Howie VM, Ploussard JH. Efficacy of fixed combination antibiotic versus separate components in otitis media. Effective-ness of erythromycin estrolate, triple sulphonamide, ampicillin, erythromycin estolate-triple sulphonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr 1972; 11: 205–214.
- Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Mi-crobiol Infect 2001; 7: 589–596.
- Jacobs MR, Felmingham D, Appelbaum PC, Griineberg RN, the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-ac-quired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229–246.
- Perez-Trallero E, Garcia-de-la-Fuente C, Garcia-Rey C, Ba-quero F, Aguilar L, Dal-Ré R et al. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to an-timicrobials in respiratory pathogenic bacteria in Spain. Antimi-crob Agents Chemother 2005; 49: 1965–1972.
- Dagan R, Leibovitz E. Bacterial eradication in the treat-ment of otitis media. Lancet Infect Dis 2002; 2: 593–604
- Dagan R, Jonson CE, McLinn S, Abughali N, Feris J, Lei-bovitz E et al. Bacteriologic and clinical efficacy of amoxicillin-clavulanate versus azithromycin in acute otitis media. Pediatr Infect Dis J 2000; 19: 95–104.
- Dagan R, Leibovitz E, Hiss DM, Leiberman A, Jacobs MR, Craig W et al. Bacteriologic efficacy of oral azithromycin and oral cefaclor in the treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000; 44: 43–50.
- Leibovitz E, Jacobs MR, Dagan R. Haemophilus influen-zae. A significant pathogen in acute otitis media. Pediatr Infect Dis J 2004; 23: 1142–1155.
- Peric M, Bozdogan B, Jacobs MR, Appelbaum PC. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimi-crob Agents Chemother 2003; 47: 1017–1022.